По вашему запросу найдено документов: 37

Страница 1 из 4

-line treatment with platinum-based chemotherapy. At present, numerous clinical trials are being conducted

(PARP) inhibitors to chemotherapy for the treatment of BRCA1-mutated or BRCA2-mutated ovarian carcinoma

Background: In the ARIEL4 trial of rucaparib versus standard-of-care chemotherapy in patients

and chemotherapy. Arsenic trioxide could inhibit various tumors. However, it is a challenge to evaluate

Chemotherapy

ПОЗДНИЕ ОСЛОЖНЕНИЯ ЛЕЧЕНИЯ БОЛЬНЫХ ГЕРМИНОГЕННЫМИ ОПУХОЛЯМИCHEMOTHERAPY

supplemented by postoperative chemotherapy. Platinum drugs are a class of chemotherapeutic drugs that affect

chemotherapy

Лечение распространенногомелкоклеточного рака легкого. Клинический случай и обзор литературыChemotherapy

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a

Страница 1 из 4